Angiotensin-Receptor Blockade and Risk of Cancer: Meta-Analysis of Randomised Controlled Trials

The Lancet Oncology- United Kingdom

doi 10.1016/s1470-2045(10)70106-6

Full Text

Abstract

Available in

Categories

Oncology

Date

Authors

Publisher

Elsevier BV

Related search

Angiotensin Receptor Blockers Use and the Risk of Lung Cancer: A Meta-Analysis

JRAAS - Journal of the Renin-Angiotensin-Aldosterone System
Internal MedicineEndocrinology
2015English

Treatment of Human Brucellosis: Systematic Review and Meta-Analysis of Randomised Controlled Trials

BMJ
2008English

Biased Safety Reporting in Blinded Randomized Clinical Trials: Meta-Analysis of Angiotensin Receptor Blocker Trials

PLoS ONE
Multidisciplinary
2013English

Statin Use and Risk of Lung Cancer: A Meta-Analysis of Observational Studies and Randomized Controlled Trials

PLoS ONE
Multidisciplinary
2013English

Promoting Physical Activity Among Cancer Survivors: Meta-Analysis and Meta-Cart Analysis of Randomized Controlled Trials.

Health Psychology
MedicinePsychiatryMental HealthApplied Psychology
2019English

Systematic Review and Meta-Analysis of Randomised, Other-Than-Placebo Controlled, Trials of Individualised Homeopathic Treatment

Homeopathy
Alternative MedicineComplementary
2018English

Cardiovascular Safety of Lumiracoxib: A Meta-Analysis of Randomised Controlled Trials in Patients With Osteoarthritis

European Journal of Clinical Pharmacology
MedicinePharmacology
2012English

A Meta-Analysis of Randomised Placebo-Controlled Treatment Trials for Depression and Anxiety in Parkinson’s Disease

PLoS ONE
Multidisciplinary
2013English

Randomised Controlled Trials

Eye
MedicineArtsSensory SystemsOphthalmologyHumanities
1995English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy